News BMS settles US off-label marketing case for $19.5m BMS illegally promoted schizophrenia drug, says attorney general
Views & Analysis How can pharma help NHS improve mental health services? Sustainability and Transformation Plans present an opportunity for pharma to support research into mental health conditions.
News Mental health the focus of new £400K NHS England digital fun... Six to eight innovations will be chosen to take part in the Digital Development Lab.
Views & Analysis Depression: 'I feel so stuck and lost and empty' A personal insight into what it's like to suffer depression
News Digital start-up gets funding for 'Sleepio' Big Health hopes improving sleep will benefit mental health.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
